Mitochondria-enriched BMSC exosomes restore microglia–neuron cross-talk in Parkinson’s disease via PINK1/parkin and PI3K/Akt/mTOR pathways
Brain Research · 2026
DOI: 10.1016/j.brainres.2026.150487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2026. Verfasst von Shanshan Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Exosomes, Microglia, Mitochondria, Parkinson Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Postdoctoral Foundation of Hei Long Jiang Province, National Natural Science Foundation of China, China Primary Health Care Foundation.
Abstract (Originalsprache)
BACKGROUND: Mitochondrial dysfunction and neuroinflammation drive dopaminergic neuron loss in Parkinson's disease (PD). While BMSC-derived small extracellular vesicles (BMSC-Exo) are neuroprotective, their ability to repair mitochondrial deficits is limited. We engineered mitochondrial-enriched sEVs (Exo-Mito) to evaluate their effects on microglia-neuron interactions in a PD-relevant model. METHODS: BMSC-Exo-Mito were characterized via TEM, NTA, and immunoblotting. Their therapeutic efficacy was assessed using an MPP + -induced BV2/SH-SY5Y transwell co-culture model. Assessments included ROS levels, mitochondrial membrane potential, ATP quantification, mitophagy flux, and signaling pathway analysis. RESULTS: Exo-Mito significantly restored mitochondrial homeostasis by reducing ROS, preserving membrane potential, and increasing ATP production. Mechanistically, Exo-Mito enhanced PINK1/Parkin-dependent mitophagy and PGC-1alpha/TFAM-mediated biogenesis. In BV2 microglia, Exo-Mito suppressed the NF-kappaB/NLRP3 axis, reduced proinflammatory cytokines, and promoted M2 polarization. In SH-SY5Y cells with dopaminergic phenotype, Exo-Mito was associated with reactivated PI3K/Akt/mTOR signaling, preserved tyrosine hydroxylase expression, and inhibited apoptosis. Functionally, Exo-Mito improved SH-SY5Y cell and restored microglial migratory capacity, showing superior efficacy to unmodified BMSC-Exo. CONCLUSION: Mitochondria-enriched BMSC sEVs protect SH-SY5Y cells by coordinating mitochondrial quality control and modulating neuroinflammation. These findings support Exo-Mito as a promising cell-free therapeutic strategy for Parkinson's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: yujunpan@ems.hrbmu.edu.cn.
- Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: wcysjnk@hrbmu.edu.cn.
Förderung
- Postdoctoral Foundation of Hei Long Jiang Province
- National Natural Science Foundation of China
- China Primary Health Care Foundation
Zitieren
APA
Shi, S., Liu, R., Liu, C., Chen, Y., Pan, Y., & Wang, C. (2026). Mitochondria-enriched BMSC exosomes restore microglia–neuron cross-talk in Parkinson’s disease via PINK1/parkin and PI3K/Akt/mTOR pathways. Brain Research. https://doi.org/10.1016/j.brainres.2026.150487
Vancouver
Shi S, Liu R, Liu C, Chen Y, Pan Y, Wang C. Mitochondria-enriched BMSC exosomes restore microglia–neuron cross-talk in Parkinson’s disease via PINK1/parkin and PI3K/Akt/mTOR pathways. Brain Research. 2026. doi:10.1016/j.brainres.2026.150487
BibTeX
@article{Shi2026,
author = {Shi, Shanshan and Liu, Ruyue and Liu, Chang and Chen, Yuyao and Pan, Yujun and Wang, Chunyan},
title = {Mitochondria-enriched BMSC exosomes restore microglia–neuron cross-talk in Parkinson’s disease via PINK1/parkin and PI3K/Akt/mTOR pathways},
journal = {Brain Research},
year = {2026},
doi = {10.1016/j.brainres.2026.150487}
}
EUVIMED